We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
NORADRENALINE MYLAN (Alphapharm Pty Ltd)
Product name
NORADRENALINE MYLAN
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
166 (255 working days)
Active ingredients
noradrenaline (norepinephrine) acid tartrate monohydrate
Registration type
New generic medicine
Indication
NORADRENALINE MYLAN (concentrated injection) is indicated for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions).
As an adjunct in the treatment of cardiac arrest. To restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.